bpc-157 human trial study The Truth About BPC 157 Peptide in Sports Medicine: What You Need to Know BPC-157 and the Difference Between

doi: 10.1148/radiol.2271010938

Microbiome-based interventions are gaining attention for their potential to modulate ENS function

Patients with these conditions require careful evaluation by their provider before initiating therapy, as they may be at increased the risk for gastrointestinal adverse effects or complications

Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: a randomized clinical trial

These data help researchers understand how gutbrain hormone systems interact and how those interactions affect appetite and metabolic readouts within controlled study designs